Phenotypic expansion of GBM high-grade tumor capabilities have been associated with novel mutations in key genes, including for example the acquisition of neuron-like signaling processes that facilitate cell survival and invasion in gliomas with IDH and histone H3 mutations [58,59]. The gene discussed is IDH2; the disease is glioblastoma.